Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lipocine (LPCN) Return on Assets (2016 - 2025)

Historic Return on Assets for Lipocine (LPCN) over the last 13 years, with Q3 2025 value amounting to 0.32%.

  • Lipocine's Return on Assets fell 1300.0% to 0.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.32%, marking a year-over-year decrease of 1300.0%. This contributed to the annual value of 0.0% for FY2024, which is 5400.0% up from last year.
  • As of Q3 2025, Lipocine's Return on Assets stood at 0.32%, which was down 1300.0% from 0.23% recorded in Q2 2025.
  • In the past 5 years, Lipocine's Return on Assets registered a high of 0.1% during Q3 2022, and its lowest value of 0.68% during Q4 2023.
  • Moreover, its 5-year median value for Return on Assets was 0.31% (2023), whereas its average is 0.27%.
  • Per our database at Business Quant, Lipocine's Return on Assets surged by 8200bps in 2021 and then tumbled by -6900bps in 2023.
  • Quarter analysis of 5 years shows Lipocine's Return on Assets stood at 0.01% in 2021, then plummeted by -1946bps to 0.28% in 2022, then tumbled by -145bps to 0.68% in 2023, then surged by 100bps to 0.0% in 2024, then crashed by -81848bps to 0.32% in 2025.
  • Its Return on Assets stands at 0.32% for Q3 2025, versus 0.23% for Q2 2025 and 0.25% for Q1 2025.